Josol, Noel .
HRN: 27-32-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2025
TENOFOVIR DISOPROXIL FUMARATE 300MG TAB
06/14/2025
06/21/2025
PO
300mg
OD
Hepatitis B Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes